Currently, these programs only apply to Ozempic and Trulicity, both prescribed for type 2 diabetes, not weight loss
Tirzepatide is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist developed for the treatment of type 2 diabetes and obesity
Savings card programs require commercial insurance and have annual caps
Oral Proteins & Peptides Market: COMPANY EVALUATION MATRIX In the oral proteins & peptides market matrix, Novo Nordisk (Star) leads with a strong market share and broad product footprint, backed by its global scale, diversified therapeutic portfolio, and integrated manufacturing capabilities that ensure a reliable supply of oral proteins and peptide drugs
Karen Mann, MD, Nooms Medical Director , for her insights
California Prop 65 Warning applies.